GPT and metabolic dysfunction-associated steatotic liver disease: Currently, liver function assessment relies on blood tests for classic biomarkers that are poorly correlated with NAFLD development, such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT) (Maximos et al, 2015).